Ex vivo comparison of ACU193 and lecanemab reveals binding differences in mouse brain.

sabirnetug IV (ACU193 IV) - Acumen Pharma

Leqembi (lecanemab-irmb) - Biogen, Eisai

http://www.ncbi.nlm.nih.gov/pubmed/42222928

Cynthia A Lemere; Elizabeth Johnson; Eric Siemers; Erika N Cline; Jasna Jerecic; Martine B Grenon

Jun 2, 2026